Health Condition 1: L501- Idiopathic urticaria
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed cases of CSU (Urticaria of more than 06 weeks duration despite the use of H1 antihistamine and without any known triggers) 2. Patients of any gender, with age between 18-60 years 3. Hives and itching for more than 06 weeks despite using H1 antihistamines 4. UAS7 Score more than or equal to 16 5. Willing to participate in the case series by signing the Informed Consent Form
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UAS7 is selected as the Primary Outcome measureTimepoint: Baseline, 30th Day, 60th Day | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in the Urticaria Control Test Scores in both groups at the end of 60th day 3 daysTimepoint: Baseline, 30th Day, 60th Day;Change in Quality of sleep assessed by using PSQI scale at the end of 60th day 3 daysTimepoint: Baseline, 30th Day, 60th Day;Change in quality of life by Perceived Stress Scale (PSS) Score at the end of 60th day 3 daysTimepoint: Baseline, 30th Day, 60th Day;Proportion of patients who experienced Adverse Drug Reactions(s) at the end of 60th day 3 daysTimepoint: 30th Day, 60th Day;Percentage of participants requiring dose escalation at the end of 60th day 3 daysTimepoint: 30th Day, 60th Day;Change in Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) at the end of 60th day 3 daysTimepoint: Baseline, 30th Day, 60th Day | — |
Countries
India
Contacts
Regional Ayurveda Research Institute, Vijayawada